AVIR Competitors & Alternatives
Compare Atea Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AVIR
Main Stock$5.43
Tradestie Score
30
Market Cap
$228.55M
Revenue Growth
3.0%
Analyst Upside
+73.4%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.55
|
$468.01M | - | 37 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$14.30
|
$463.20M | - | 55 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$9.30
|
$457.09M | - | 39 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$8.64
|
$454.29M | - | 43 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$15.76
|
$448.32M | - | 49 | Compare |
|
AUTL
Autolus Therapeutics plc American Depositary Share
|
$2.41
|
$444.46M | - | 31 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$24.17
|
$422.50M | - | 57 | Compare |
More AVIR Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry